News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current FAB market cap is 5.58M. The company's latest EPS is GBP -0.0233 and P/E is -2.51.
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 3.9M | 4.17M | 4.8M | 2.9M | 1.14M |
| Operating Income | -1.06M | -1.19M | -1.35M | -2.89M | -2.3M |
| Net Income | -697k | -2.9M | -1.2M | -2.6M | -2.23M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 6.04M | 5.83M | 4.92M | 2.06M | 2.42M |
| Total Liabilities | 1.23M | 1.08M | 1.23M | 939k | 627k |
| Total Equity | 4.81M | 4.75M | 3.68M | 1.12M | 1.79M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -160k | -1.14M | -325k | -1.75M | -1.77M |
| Investing | -103k | -362k | -257k | -111k | 1,000 |
| Financing | -184k | 2.65M | -55k | 3k | 2.77M |
| Market Cap | 5.58M |
| Price to Earnings Ratio | -2.51 |
| Price to Sales Ratio | 4.92 |
| Price to Cash Ratio | 4.64 |
| Price to Book Ratio | 3.11 |
| Dividend Yield | - |
| Shares Outstanding | 95.37M |
| Average Volume (1 week) | 71.78k |
| Average Volume (1 Month) | 401.46k |
| 52 Week Change | 30.00% |
| 52 Week High | 8.25 |
| 52 Week Low | 2.90 |
| Spread (Intraday) | 0.3 (5%) |
| Company Name | Fusion Antibodies Plc |
| Address |
1 springbank road belfast BT17 0QL |
| Website | https://www.fusionantibodies.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
